Thus, identifying factors capable of modulating the functioning and/or expression levels of Pgrn itself in other cell types is essential, as knowledge of such regulatory factors will not only impart invaluable information regarding the underlying pathophysiology of PGRN-associated neurodegenerative diseases but also uncover novel putative targets for therapeutic intervention. The gene discussed is GRN; the disease is neurodegenerative disease.